For instance, Cryopyrin-associated periodic syndromes (CAPS) are caused by gain-of-function mutations in the NLRP3 gene that result in the constitutive activation of the NLRP3 inflammasome and the release of IL-1β, in turn responsible for the symptomatology of the disease [84]. Here, NLRP3 is linked to cryopyrin-associated periodic syndrome.